RMMS Partner William Rakoczy Recognized by Chambers & Partners Awards & Recognition July 28, 2017 Read More
RMMS Scores Win in Europe Relating to Shire’s Factor VIII ADVATE Franchise Biologics May 16, 2017 Read More
RMMS Named “U.S. Firm to Watch” by Managing Intellectual Property Magazine Awards & Recognition March 23, 2017 Read More
Federal Circuit Affirms Collateral Estoppel Decision Concerning Latisse® (bimatoprost topical solution) Small Molecules March 17, 2017 Read More
RMMS Secures Invalidity Win on Copaxone® 40 (glatiramer acetate 40 mg/mL) Small Molecules January 30, 2017 Read More
RMMS Secures Invalidity And Non-Infringement Victories on Patents Related To Axiron® (Testosterone) Transdermal Solution Medical DevicesSmall Molecules August 22, 2016 Read More
RMMS Recognized As Second Most Active Firm Representing Defendants in Hatch-Waxman Cases Small Molecules April 27, 2016 Read More
Federal Circuit Affirms Judgment of Invalidity Concerning OxyContin® (oxycodone extended-release tablets) Small Molecules February 1, 2016 Read More
RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®) Small Molecules November 16, 2015 Read More
RMMS Recognized as Industry Leaders by LMG Life Sciences for Fourth Consecutive Year Awards & Recognition October 20, 2015 Read More
RMMS Secures Summary Judgment Against Otsuka Related To Generic Aripiprazole (Abilify®) Small Molecules May 27, 2015 Read More
Federal Circuit Affirms Judgment of Invalidity Concerning Pulmicort Respules® (budesonide inhalation suspension) Small Molecules May 7, 2015 Read More
RMMS Secures Second Victory Against Otsuka Related To Generic Aripiprazole (Abilify®) Small Molecules April 30, 2015 Read More
Chief Judge Simandle Allows Launch of Generic Aripiprazole (Abilify®) Small Molecules April 16, 2015 Read More
Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions Small Molecules March 20, 2015 Read More
RMMS Files Supreme Court Amicus Brief on Behalf of GPhA Supporting Specific-Intent-to-Infringe Requirement for Induced Infringement Counseling February 26, 2015 Read More
RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension) Small Molecules February 13, 2015 Read More
Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets Small Molecules February 12, 2015 Read More
RMMS Recognized as Industry Leaders by LMG Life Sciences Awards & Recognition November 7, 2014 Read More
RMMS Secures Reversal Before Federal Circuit, Invalidating Asserted Patents Concerning Latisse® (bimatoprost) Ophthalmic Solution Small Molecules July 10, 2014 Read More
U.S. Court Of Appeals For The Federal Circuit Affirms RMMS’s Victory Involving Generic Ibandronate Products Small Molecules April 11, 2014 Read More